Your browser is no longer supported. Please, upgrade your browser.
Innoviva, Inc.
Index- P/E6.50 EPS (ttm)2.48 Insider Own0.70% Shs Outstand88.42M Perf Week-2.48%
Market Cap1.13B Forward P/E10.00 EPS next Y1.61 Insider Trans3.62% Shs Float69.02M Perf Month-6.40%
Income265.20M PEG0.34 EPS next Q0.43 Inst Own71.41% Short Float13.96% Perf Quarter14.18%
Sales365.50M P/S3.09 EPS this Y45.50% Inst Trans-0.33% Short Ratio12.20 Perf Half Y37.96%
Book/sh3.73 P/B4.32 EPS next Y-20.30% ROA27.90% Target Price10.00 Perf Year67.19%
Cash/sh- P/C- EPS next 5Y19.34% ROE53.30% 52W Range9.21 - 17.45 Perf YTD29.94%
Dividend- P/FCF- EPS past 5Y70.50% ROI28.20% 52W High-7.74% Beta0.45
Dividend %- Quick Ratio27.60 Sales past 5Y44.20% Gross Margin- 52W Low74.81% ATR0.46
Employees5 Current Ratio27.60 Sales Q/Q27.80% Oper. Margin94.50% RSI (14)46.16 Volatility2.72% 2.75%
OptionableYes Debt/Eq1.18 EPS Q/Q30.30% Profit Margin72.60% Rel Volume0.62 Prev Close15.91
ShortableYes LT Debt/Eq1.18 EarningsOct 27 AMC Payout0.00% Avg Volume789.70K Price16.10
Recom4.00 SMA20-3.24% SMA500.15% SMA20018.99% Volume487,790 Change1.19%
Nov-20-17Initiated Deutsche Bank Hold $13
Oct-27-21 04:05PM  
Oct-12-21 01:43PM  
Oct-08-21 03:28PM  
Jul-28-21 04:05PM  
Jul-16-21 03:58AM  
Jun-10-21 04:44AM  
Jun-08-21 03:16PM  
May-20-21 09:40AM  
May-05-21 04:05PM  
May-03-21 04:05PM  
Apr-28-21 04:05PM  
Mar-17-21 04:01PM  
Mar-08-21 07:03AM  
Mar-05-21 01:06AM  
Feb-03-21 05:44PM  
Feb-02-21 08:52AM  
Jan-27-21 07:01AM  
Jan-26-21 05:50PM  
Jan-05-21 10:37AM  
Jan-04-21 10:11AM  
Jan-01-21 11:50AM  
Dec-29-20 01:09PM  
Dec-28-20 11:38AM  
Dec-24-20 09:21AM  
Dec-18-20 09:30PM  
Dec-16-20 11:50AM  
Dec-10-20 08:42AM  
Dec-09-20 11:44AM  
Dec-07-20 10:07AM  
Dec-03-20 11:17AM  
Dec-02-20 07:48AM  
Dec-01-20 08:29AM  
Nov-30-20 11:50AM  
Nov-27-20 08:29AM  
Nov-24-20 09:08AM  
Nov-19-20 08:20AM  
Nov-17-20 08:23AM  
Nov-02-20 10:23AM  
Oct-28-20 04:30PM  
Oct-13-20 03:28PM  
Oct-12-20 10:19AM  
Sep-25-20 07:09AM  
Sep-10-20 11:06AM  
Sep-09-20 06:45PM  
Sep-03-20 08:30AM  
Aug-28-20 08:00AM  
Aug-24-20 11:35AM  
Aug-04-20 11:33AM  
Jul-29-20 04:05PM  
Jul-27-20 02:32PM  
Jul-20-20 11:17AM  
Jul-06-20 12:58PM  
Jun-23-20 08:34PM  
Jun-11-20 04:05PM  
Jun-09-20 05:50PM  
Jun-08-20 11:50AM  
Jun-03-20 05:50PM  
May-28-20 05:50PM  
May-26-20 09:05AM  
May-21-20 04:05PM  
May-19-20 11:30AM  
May-10-20 03:19PM  
May-07-20 04:05PM  
May-06-20 10:03AM  
May-05-20 11:50AM  
May-01-20 11:30AM  
Apr-29-20 04:05PM  
Apr-28-20 11:58AM  
Apr-23-20 11:37AM  
Apr-22-20 04:05PM  
Apr-19-20 09:11AM  
Apr-16-20 11:50AM  
Apr-07-20 09:47AM  
Mar-31-20 04:05PM  
Mar-30-20 07:30AM  
Mar-20-20 07:03AM  
Mar-09-20 01:30PM  
Mar-06-20 09:02AM  
Feb-27-20 09:36AM  
Feb-25-20 09:05AM  
Feb-12-20 08:02AM  
Feb-04-20 10:19AM  
Jan-28-20 07:00AM  
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zhen MarianneChief Accounting OfficerAug 19Sale16.022,80244,88836,493Aug 23 05:02 PM
Bickerstaff GeorgeDirectorMay 24Buy13.4610,000134,619124,560May 25 06:44 PM
Bickerstaff GeorgeDirectorMay 21Buy12.9710,000129,670114,560May 25 06:44 PM
Innoviva, Inc.DirectorMar 17Buy3.254,285,93513,929,2896,153,847Mar 17 05:16 PM
Innoviva, Inc.DirectorJan 26Buy3.251,867,9126,070,7141,867,912Jan 28 01:43 PM